Confronta i metodi

	EORTC QLQ-CX24: Qualità della Vita nel Cancro Cervicale	FACT-Ovarian: Valutazione Funzionale della Terapia Oncologica
Campo	Oncologia	Oncologia
Famiglia	Process / pipeline	Process / pipeline
Anno di origine	2006	2001
Ideatore	Greimel, E. R., et al. (EORTC Quality of Life Group)	Basen-Engquist, K., et al. (built on Cella, D. F. FACT-G framework)
Tipo	Self-report questionnaire	Self-report questionnaire
Fonte seminale	Greimel, E. R., Kuljanic Vlasic, K., Zwahlen, D., Rand, K., Heitz, U., Havsteen, H., et al. (2006). The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24. Acta Oncol, 45(3), 344–351.	Basen-Engquist, K., Bodurka, D. C., Lu, H., Sill, M. W., Thaker, P. H., Deavers, M. T., et al. (2001). Reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian (FACT-O) quality of life instrument. Gynecol Oncol, 89(3), 478–488.
Alias	QLQ-CX24	FACT-O
Correlati	5	5
Sintesi	The EORTC QLQ-CX24 is a 24-item cervical-cancer-specific module designed to complement the EORTC QLQ-C30 core questionnaire. Developed by Greimel et al. in 2006, it measures sexual/vaginal function, body image, lymphedema, neuropathy, and gastrointestinal symptoms specific to cervical cancer and its treatments. It is the standard cervical cancer-specific QoL instrument in international oncology research.	The FACT-Ovarian (FACT-O) is a disease-specific quality-of-life measure for women with ovarian cancer, integrating the 27-item FACT-G core with a 12-item ovarian-specific subscale addressing cancer-related symptoms, sexual function, abdominal distension, and treatment side effects. Validated by Basen-Engquist et al. in 2001, it is a standard endpoint in ovarian cancer clinical trials and supportive care research.